2-(4-(4-fluorophenyl)-1-methyl-1H-pyrazolo[3,4-b]pyridin-6-yl)-N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)hydrazine-1-carboxamide

ID: ALA5183850

Chembl Id: CHEMBL5183850

PubChem CID: 168283355

Max Phase: Preclinical

Molecular Formula: C30H25FN10O

Molecular Weight: 560.60

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(NC(=O)NNc2cc(-c3ccc(F)cc3)c3cnn(C)c3n2)cc1Nc1nccc(-c2cccnc2)n1

Standard InChI:  InChI=1S/C30H25FN10O/c1-18-5-10-22(14-26(18)37-29-33-13-11-25(36-29)20-4-3-12-32-16-20)35-30(42)40-39-27-15-23(19-6-8-21(31)9-7-19)24-17-34-41(2)28(24)38-27/h3-17H,1-2H3,(H,38,39)(H,33,36,37)(H2,35,40,42)

Standard InChI Key:  STEHEMHSOBIXGI-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5183850

    ---

Associated Targets(Human)

S1PR2 Tchem Sphingosine 1-phosphate receptor Edg-5 (1593 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SW620/5-FU (115 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 560.60Molecular Weight (Monoisotopic): 560.2197AlogP: 5.83#Rotatable Bonds: 7
Polar Surface Area: 134.57Molecular Species: NEUTRALHBA: 9HBD: 4
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.50CX Basic pKa: 4.26CX LogP: 5.48CX LogD: 5.48
Aromatic Rings: 6Heavy Atoms: 42QED Weighted: 0.18Np Likeness Score: -1.94

References

1. Luo D, Guo Z, Zhao X, Wu L, Liu X, Zhang Y, Zhang Y, Deng Z, Qu X, Cui S, Wan S..  (2022)  Novel 5-fluorouracil sensitizers for colorectal cancer therapy: Design and synthesis of S1P receptor 2 (S1PR2) antagonists.,  227  [PMID:34688013] [10.1016/j.ejmech.2021.113923]

Source